Tower Research Capital LLC TRC Acquires 5,639 Shares of Teleflex Incorporated (NYSE:TFX)

Tower Research Capital LLC TRC raised its holdings in shares of Teleflex Incorporated (NYSE:TFXFree Report) by 251.2% in the fourth quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 7,884 shares of the medical technology company’s stock after purchasing an additional 5,639 shares during the period. Tower Research Capital LLC TRC’s holdings in Teleflex were worth $1,966,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also made changes to their positions in the business. Amalgamated Bank grew its holdings in shares of Teleflex by 4.7% during the third quarter. Amalgamated Bank now owns 12,526 shares of the medical technology company’s stock valued at $2,460,000 after buying an additional 563 shares during the last quarter. Charles Schwab Investment Management Inc. grew its holdings in shares of Teleflex by 1.1% during the third quarter. Charles Schwab Investment Management Inc. now owns 393,053 shares of the medical technology company’s stock valued at $77,200,000 after buying an additional 4,415 shares during the last quarter. Vanguard Personalized Indexing Management LLC grew its holdings in shares of Teleflex by 8.3% during the third quarter. Vanguard Personalized Indexing Management LLC now owns 3,220 shares of the medical technology company’s stock valued at $632,000 after buying an additional 248 shares during the last quarter. Pathstone Family Office LLC grew its holdings in shares of Teleflex by 103.9% during the third quarter. Pathstone Family Office LLC now owns 2,088 shares of the medical technology company’s stock valued at $410,000 after buying an additional 1,064 shares during the last quarter. Finally, Huntington National Bank grew its holdings in shares of Teleflex by 26.5% during the third quarter. Huntington National Bank now owns 253 shares of the medical technology company’s stock valued at $50,000 after buying an additional 53 shares during the last quarter. Institutional investors own 95.62% of the company’s stock.

Analyst Ratings Changes

A number of equities research analysts have recently commented on TFX shares. StockNews.com cut shares of Teleflex from a “buy” rating to a “hold” rating in a report on Friday, February 23rd. Needham & Company LLC restated a “hold” rating on shares of Teleflex in a report on Friday, May 3rd. Royal Bank of Canada dropped their target price on shares of Teleflex from $272.00 to $265.00 and set an “outperform” rating on the stock in a report on Friday, February 23rd. Truist Financial dropped their target price on shares of Teleflex from $240.00 to $219.00 and set a “hold” rating on the stock in a report on Friday, May 3rd. Finally, JMP Securities restated a “market outperform” rating and issued a $285.00 target price on shares of Teleflex in a report on Friday, February 23rd. Four equities research analysts have rated the stock with a hold rating and five have assigned a buy rating to the company. According to MarketBeat, Teleflex presently has a consensus rating of “Moderate Buy” and a consensus target price of $257.29.

Get Our Latest Report on TFX

Teleflex Trading Down 1.8 %

Shares of Teleflex stock opened at $212.57 on Monday. The company’s fifty day simple moving average is $210.71 and its 200-day simple moving average is $228.38. The stock has a market capitalization of $10.01 billion, a PE ratio of 34.12, a P/E/G ratio of 2.06 and a beta of 1.16. Teleflex Incorporated has a 1-year low of $177.63 and a 1-year high of $262.97. The company has a debt-to-equity ratio of 0.37, a current ratio of 2.51 and a quick ratio of 1.41.

Teleflex (NYSE:TFXGet Free Report) last announced its quarterly earnings data on Thursday, May 2nd. The medical technology company reported $3.21 EPS for the quarter, beating the consensus estimate of $3.07 by $0.14. The firm had revenue of $737.80 million for the quarter, compared to the consensus estimate of $726.85 million. Teleflex had a net margin of 9.82% and a return on equity of 14.78%. The company’s revenue was up 3.8% on a year-over-year basis. During the same period last year, the firm earned $3.09 EPS. As a group, equities analysts anticipate that Teleflex Incorporated will post 13.75 earnings per share for the current year.

Teleflex Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, June 14th. Stockholders of record on Wednesday, May 15th will be given a dividend of $0.34 per share. The ex-dividend date of this dividend is Tuesday, May 14th. This represents a $1.36 annualized dividend and a dividend yield of 0.64%. Teleflex’s payout ratio is 21.83%.

Teleflex Company Profile

(Free Report)

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.

Featured Articles

Want to see what other hedge funds are holding TFX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Teleflex Incorporated (NYSE:TFXFree Report).

Institutional Ownership by Quarter for Teleflex (NYSE:TFX)

Receive News & Ratings for Teleflex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teleflex and related companies with MarketBeat.com's FREE daily email newsletter.